The DOI matches its Crossref record.
Comparison of the Structure and Function of Phospholamban and the Arginine-14 Deficient Mutant Associated with Dilated Cardiomyopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the molecular etiologies for these mutants’ lack of phosphorylation are dissimilar (21, 48).”
From Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation (2015) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 47
- AD Wegener, 1984, Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels - Evidence for a protein-structure consisting of multiple identical phosphorylatable subunits, J Biol Chem, 259, 1834, 10.1016/S0021-9258(17)43484-3 · DOI · Paper page
- J Fujii, 1987, Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban, J Clin Invest, 79, 301, 10.1172/JCI112799 · DOI · Paper page
- M Tada, 1983, Regulation of calcium transport by the ATPase-phospholamban system, J Mol Cell Cardiol, 15, 565, 10.1016/0022-2828(83)90267-5 · doi:10.1016/0022-2828(83)90267-5
- KL Koss, 1996, Phospholamban: A prominent regulator of myocardial contractility, Circ Res, 79, 1059, 10.1161/01.RES.79.6.1059 · DOI · Paper page
- P James, 1989, Nature and site of phospholamban regulation of the Ca-2+ pump of sarcoplasmic-reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
- WA Jackson, 1996, Translation of Ser(16) and Thr(17) phosphorylation of phospholamban into Ca2+-pump stimulation, Biochem J, 316, 201, 10.1042/bj3160201 · DOI
- S Negash, 2000, Phospholamban remains associated with the Ca2+- and Mg2+- dependent ATPase following phosphorylation by cAMP-dependent protein kinase, Biochem J, 351, 195, 10.1042/bj3510195 · DOI
- Y Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J Biol Chem, 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
- SL Robia, 2007, Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circulation Research, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
- R Verardi, 2011, Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method, Proceedings of the National Academy of Sciences of the United States of America, 108, 9101, 10.1073/pnas.1016535108 · DOI · Paper page
- J Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys J, 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI · Paper page
- NJ Traaseth, 2009, Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach, Proceedings of the National Academy of Sciences of the United States of America, 106, 10165, 10.1073/pnas.0904290106 · DOI · Paper page
- S Abu-Baker, 2007, The structural topology of wild-type phospholamban in oriented lipid bilayers using N-15 solid-state NMR spectroscopy, Protein Science, 16, 2345, 10.1110/ps.072977707 · DOI · Paper page
- M Gustavsson, 2011, Lipid-Mediated Folding/Unfolding of Phospholamban as a Regulatory Mechanism for the Sarcoplasmic Reticulum Ca(2+)-ATPase, Journal of Molecular Biology, 408, 755, 10.1016/j.jmb.2011.03.015 · DOI · Paper page
- LR Masterson, 2011, cAMP-Dependent Protein Kinase A Selects the Excited State of the Membrane Substrate Phospholamban, Journal of Molecular Biology, 412, 155, 10.1016/j.jmb.2011.06.041 · DOI · Paper page
- JP Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- K Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proceedings of the National Academy of Sciences of the United States of America, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- PA van der Zwaag, 2012, Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy, European Journal of Heart Failure, 14, 1199, 10.1093/eurjhf/hfs119 · DOI · Paper page
- KN Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proceedings of the National Academy of Sciences of the United States of America, 108, 2735
- JP Schmitt, 2009, Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca2+-ATPase Inhibition, Circulation, 119, 436, 10.1161/CIRCULATIONAHA.108.783506 · DOI
- K Haghighi, 2012, The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase, Journal of Molecular and Cellular Cardiology, 52, 773, 10.1016/j.yjmcc.2011.11.012 · DOI · Paper page
- DK Ceholski, 2012, Lethal, Hereditary Mutants of Phospholamban Elude Phosphorylation by Protein Kinase A, Journal of Biological Chemistry, 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
- J East, 1982, Lipid selectivity of the Ca2+ and Mg2+ ion dependent adenosinetriphosphate studied with fluorescence quenching by a bromine phospholipid, Biochemistry, 21, 4144, 10.1021/bi00260a035 · DOI · Paper page
- B Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expression and Purification, 30, 253, 10.1016/S1046-5928(03)00127-X · DOI · Paper page
- JL Douglas, 2005, Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies, Protein Expr Purif, 40, 118, 10.1016/j.pep.2004.11.015 · doi:10.1016/j.pep.2004.11.015
- E Hughes, 2010, Heparin-derived oligosaccharides interact with the phospholamban cytoplasmic domain and stimulate SERCA function, Biochemical and Biophysical Research Communications, 401, 370, 10.1016/j.bbrc.2010.09.056 · DOI
- J Hu, 2007, Structural biology of transmembrane domains: Efficient production and characterization of transmembrane peptides by NMR, Protein Science, 16, 2153, 10.1110/ps.072996707 · DOI
- KA Dalton, 1999, Anionic phospholipids decrease the rate of slippage on the Ca2+-ATPase of sarcoplasmic reticulum, Biochem J, 342, 431, 10.1042/bj3420431 · doi:10.1042/bj3420431
- D Levy, 1992, Reconstitution of the sarcoplasmic-reticulum Ca2+-Atpase - mechanisms of membrane-protein insertion into liposomes during reconstitution procedures involving the use of detergents, Biochim Biophys Acta, 1107, 283, 10.1016/0005-2736(92)90415-I · doi:10.1016/0005-2736(92)90415-i
- E Hughes, 2003, Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase, J Biol Chem, 278, 20835, 10.1074/jbc.M212208200 · doi:10.1074/jbc.m212208200
- T Toyofuku, 1994, Amino-acids Glu(2) to Ile(18) in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+-Atpase of sarcoplasmic-reticulum, J Biol Chem, 269, 3088, 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
- A Yoda, 1970, On reversibility of binding cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphate from beef brain, Biochemical and Biophysical Research Communications, 40, 880, 10.1016/0006-291X(70)90985-X · doi:10.1016/0006-291x(70)90985-x
- LG Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
- M Li, 1998, Phosphorylation-induced structural change in phospholamban and its mutants, detected by intrinsic fluorescence, Biochemistry, 37, 7869, 10.1021/bi9801053 · DOI
- P Cook, 1982, Adenosine cyclic 3', 5' - monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit, Biochemistry, 21, 5794, 10.1021/bi00266a011 · DOI · Paper page
- DK Ceholski, 2012, Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy, Journal of Biological Chemistry, 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
- OC Andronesi, 2005, Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy, Journal of the American Chemical Society, 127, 12965, 10.1021/ja0530164 · DOI · Paper page
- E Hughes, 2009, Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: A new role for phospholipids in the regulation of cardiac calcium cycling?, Biochimica Et Biophysica Acta-Biomembranes, 1788, 559, 10.1016/j.bbamem.2008.10.029 · doi:10.1016/j.bbamem.2008.10.029
- G Hughes, 1996, An investigation of the mechanism of inhibition of the Ca2+- ATPase by phospholamban, Biochem J, 318, 973, 10.1042/bj3180973 · DOI
- JR Waggoner, 2007, Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate, Biochemistry, 46, 1999, 10.1021/bi061365k · DOI
- T Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J Biol Chem, 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
- BL Akin, 2010, Superinhibitory Phospholamban Mutants Compete with Ca2+ for Binding to SERCA2a by Stabilizing a Unique Nucleotide-dependent Conformational State, Journal of Biological Chemistry, 285, 28540, 10.1074/jbc.M110.151779 · DOI · Paper page
- EL Lockamy, 2011, Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure, Biochemical and Biophysical Research Communications, 408, 388, 10.1016/j.bbrc.2011.04.023 · DOI
- SJ Gruber, 2012, Phospholamban mutants compete with wild type for SERCA binding in living cells, Biochemical and Biophysical Research Communications, 420, 236, 10.1016/j.bbrc.2012.02.125 · doi:10.1016/j.bbrc.2012.02.125
- JE Mahaney, 2000, Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: New insights on Ca-ATPase regulation by phospholamban, Biophys J, 78, 1306, 10.1016/S0006-3495(00)76686-0 · doi:10.1016/s0006-3495(00)76686-0
- E Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J Biol Chem, 275, 14985, 10.1074/jbc.275.20.14985 · DOI
- M Sayadi, 2010, Effect of Membrane Thickness on Conformational Sampling of Phospholamban from Computer Simulations, Biophysical Journal, 98, 805, 10.1016/j.bpj.2009.11.015 · DOI
Cited by
Kim, J., Masterson, L. R., Cembran, A., Verardi, R., Shi, L., Gao, J., Taylor, S. S., & Veglia, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502299112 · Cited by 45
Metadata
- Authors
- Hughes, E., & Middleton, D. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-16
- Volume
- 9
- Issue
- 9
- Pages
- e106746
- ISSN
- 1932-6203
- Cited by
- 17
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.